Jynarque 90MG-30MG
Ended Awarded
- Contract number
- 36C24524N0112
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,196
Award facts
- Contract value 100% obligated
- $12,195.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc., a specialty pharmaceutical manufacturer headquartered in Rockville, Maryland, was awarded a delivery order valued at $12,195.72 by Veterans Integrated Service Network 5 on October 24, 2023, for JYNARQUE 90MG-30MG. This firm-fixed price contract, which has no set-aside designation, represents a delivery order issued under the parent Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) for performance in Pittsburgh, Pennsylvania, with an ultimate completion date of October 27, 2023. The funding originates from the Department of Veterans Affairs, a civilian federal agency serving the nation's veteran population.
This award is part of Otsuka America Pharmaceutical Inc.'s broader engagement with the VA to supply Jynarque (tolvaptan), a specialized pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. The contractor maintains significant indefinite delivery vehicles with the VA, including an $83.3 million Blanket Purchase Agreement for Jynarque awarded by the National Acquisition Center through March 26, 2026, and a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology products. These vehicles enable VA facilities across multiple Veterans Integrated Service Networks to efficiently procure critical pharmaceutical treatments for veterans nationwide, streamlining the procurement process for specialized medical interventions.
Quick answers
Who was awarded contract 36C24524N0112?
36C24524N0112 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on October 24, 2023.
How much is contract 36C24524N0112 worth?
The government has obligated $12,196 on 36C24524N0112.
Is contract 36C24524N0112 an order under another contract?
Yes. 36C24524N0112 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24524N0112 competed?
The extent of competition for 36C24524N0112 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award